% | $
Quotes you view appear here for quick access.

Rockwell Medical, Inc. Message Board

  • kentpick kentpick Sep 13, 2013 3:43 PM Flag

    Note fr Upgrade: SFP potential for SOC usage

    real-time news and commentary for investorsMarket Currents Friday, Sep 13
    9:47 AMRockwell Medical rises on Craig-Hallum note, SFP in focus
    Rockwell Medical (RMTI +12.4%) trades higher in early action.Craig-Hallum has initiated the shares at Buy with a $16 price target (slightly less optimistic than the $25 objective Summer Street slapped on the shares post-CRUISE-2).The firm thinks SFP is set to become the standard of care.Apparently mentioned in the note is RMTI's potential to reduce erythropoiesis stimulating agent usage. This may end up threatening Amgen's (AMGN) Epogen and Aranesp, although, as SA contributor Paulo Santos notes, the potential hit to Aranesp might be a larger concern because Epogen is "losing patent protection now, so it's going to be pressured anyway."

    SortNewest  |  Oldest  |  Most Replied Expand all replies
7.98-0.02(-0.25%)Jul 22 4:00 PMEDT